Study Design. This study evaluated safety, fusion success rate, and cl
inical outcome of a new lumbar interbody hollow, threaded titanium fus
ion cage in a multicenter, prospective 236-case program adhering to a
United States Food and Drug Administration Investigational Device Exem
ption-controlled protocol. Objectives. The results were evaluated to d
emonstrate the safety and effectiveness of this new method to achieve
solid lumbar interbody fusions. Summary of Background Data. Interbody
fusions have certain distinct mechanical advantages over lateral or po
sterolateral ones. Autologous, cancellous bone is the preferred graft
material, but is too soft to maintain the space during fusion without
mechanical support. Various methods have been used in the past to main
tain the graft integrity during fusion development. Methods. An initia
l pilot study began on 10 patients (followed for 84 months, average 80
months). Two years after that investigation started, the multicenter
United States Food and Drug Administration Investigational Device Exem
ption study began, with cases followed for 28-46 months (average, 32).
Ninety-six percent of the Investigational Device Exemption study case
s had severe, disabling back pain; in addition, 74% had major anular d
egeneration; 57% had herniations; 21% had osteophytes; and 43% had dis
c height reduced by greater than 10%. Forty-five percent of cases had
previous spinal surgeries, and none were posterior lumbar interbody fu
sions. Titanium fusion cage pairs were screwed into bored and threaded
, parallel intradiscal holes, and 3-8 ml autologous cancellous bone wa
s packed inside each. Fusion success was judged by absence of motion o
n flexion-extension radiographs, absence of bone halo around the impla
nts, and maintenance of visible bone inside the cages on Ferguson view
radiographs. Results. Segments fused rapidly; the pilot study cases f
used at 10 (91%) of 11 levels, with a reported 80% average clinical im
provement. Ninety-six percent of the 208 2 year follow-up Investigatio
nal Device Exemption cases had fusion, and the Prolo socioeconomic/fun
ctional improvement scale showed: 40% excellent, 25% good, 21% fair, a
nd 14% poor results. Less than 1% of Investigational Device Exemption
cases had complications that persisted beyond the average 5 days of ho
spitalization, and none were serious. Conclusions. The Ray titanium fu
sion cage (Surgical Dynamics, Norwalk, CT) implant method has been fou
nd to be an effective, rapid, safe procedure for lumbar spine fusions,
demonstrating a high fusion rate and clinical success with rare, seri
ous, or permanent complications.